Coby Health semaglutide review
Advertised at $179, billed at $229. Position 10 of 14 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
About $229 a month, or $179 on multi-month, supplies included, no membership.
Coby states on its own product pages that compounded semaglutide is not FDA-reviewed and is not a generic of Ozempic or Wegovy. The desk notes that, because almost nobody else does.
The numbers
| Coby Health · semaglutide | |
|---|---|
| Advertised | $179/mo |
| Membership | None |
| Billed | $229/mo |
| Advertised-to-billed gap | +$50/mo |
| Per year | $2,748 |
| Board position | 10 of 14, cheapest first |
Same structure — multi-month plans carry the lower rate.
Where the gap is
Only the monthly-versus-multi-month spread, which is stated up front.
Against the board
Roughly $2,148 to $2,748 a year. Mid-board.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $99 | $149 | +$50 | +$63/mo |
| Ozari Health | $86 | $86 | none | — |
| Trimi | $99 | $99 | none | +$13/mo |
| Zealthy | $151 | $151 | none | +$65/mo |
| Mochi Health | $99 | $178 | +$79 | +$92/mo |
| Hims & Hers | $79 | $188 | +$109 | +$102/mo |
| PlexusDx | $129 | $189 | +$60 | +$103/mo |
| Eden | $99 | $198 | +$99 | +$112/mo |
How the programme works
Compounded GLP-1 provider selling monthly and multi-month plans with an at-home injection kit included in the price.
Verified facts
- Compounded tirzepatide listed at $239/month on the monthly plan, down from $299.
- Multi-month plans bring compounded tirzepatide to about $179/month.
- An at-home injection kit with alcohol pads and syringes is included.
- Monthly plans can be cancelled at any time.
- States plainly on its own product pages that compounded medication is not FDA-reviewed or approved.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Injection supplies are included rather than something you source yourself.
- Monthly plan is genuinely cancel-anytime.
- Unusually clear on its own pages that the product is not FDA-approved.
Against it
- The lowest advertised rate requires a multi-month commitment.
- Less published detail on clinical support than the larger platforms.
Read this bit. The $179 figure is a multi-month rate. Month-to-month is $239.
Score
3.6 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.7 / 5 |
| Price honesty | 20% | 3.6 / 5 |
| Clinical support | 20% | 3.3 / 5 |
| Pharmacy sourcing | 15% | 3.4 / 5 |
| Cancelling | 15% | 3.7 / 5 |
Verdict
Honest mid-market listing. No gap worth reporting, which on this board is itself news.
More from the desk
- Coreage Rx semaglutide review
Advertised at $99, billed at $149. Position 1 of 14 on our board.
- Ozari Health semaglutide review
Advertised at $86 and billed at $86 — no gap. Position 2 of 14 on our board.
- Trimi semaglutide review
Advertised at $99 and billed at $99 — no gap. Position 3 of 14 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.